A concise assessment of AI’s diagnostic strengths in imaging and telehealth, the main reliability limits, and why clinician oversight remains essential.
AI in Healthcare Diagnosis: Promise, Limits, and the Case for Human Oversight Read More »
PreciseDx joins industry leaders at the NYC Leadership Summit to discuss AI-driven drug discovery, PreciseBreast, and the balance between innovation and regulation.
A concise AI-focused analysis of recent UK health developments and what they mean for AI adoption across the NHS, workforce and patient access.
UK Healthcare Trends: An AI Insider’s Perspective on the NHS 10-Year Plan Read More »
Discover how AI and biotechnology together drive sustainable food production, unlock revenue in alternative proteins and precision fermentation, and optimize supply chains.
How AI and Biotech Are Powering New Growth in the Food Industry Read More »
Explore how AI is intersecting with UK clinical trials, diagnostics and digital triage to relieve A&E pressure and accelerate NHS innovation.
How AI Is Shaping UK Healthcare: From Liver Trials to Smarter A&E Pathways Read More »
AI models in cancer pathology can learn patient demographics from slides, producing unequal diagnostic performance. FAIR-Path uses contrastive learning to cut disparities by ~88%.
Unmasking Demographic Bias in AI Cancer Pathology and the FAIR-Path Solution Read More »
New research shows pathology AI can infer patient demographics from tissue and skew cancer diagnoses. FAIR-Path uses contrastive learning to cut disparities and guide fairer models.
FAIR-Path and the Fight Against Demographic Bias in Pathology AI Read More »
How machine learning and deep learning are reshaping diagnostic imaging, supporting clinicians, improving precision, and the practical steps for responsible clinical adoption.
AI in Diagnostic Imaging: Transforming Clinical Decision-Making Read More »
MHRA invites views on regulating AI in UK healthcare. Stakeholders, patients and industry can respond by 2 Feb 2026 to shape safety, trust and responsibilities.
UK Regulator Seeks Input on AI Healthcare Rules Read More »
Medra closed a $52M Series A to expand robotic labs and ‘Physical AI Scientists’ that link AI predictions to real experiments, speeding drug discovery for patients.
Medra Raises $52M to Scale ‘Physical AI Scientists’ and Robotic Drug Discovery Read More »
